English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [3997]
News [12071]
Articles [49]
Editorials [10]
Conferences [217]
elearning [4]
AACR 2024: PARP1-selective inhibitor demonstrates early efficacy in breast cancers with DNA repair defects
AACR 2024: PARP1-selective inhibitor demonstrates early efficacy in breast cancers with DNA repair defects
AACR 2024: Adagrasib plus cetuximab may provide clinical benefit in patients with KRASG12c-mutated colorectal cancer
AACR 2024: Adagrasib plus cetuximab may provide clinical benefit in patients with KRASG12c-mutated colorectal...
AACR 2024: Novel ADC and immunotherapy combo shows promise in endometrial cancer subtype
AACR 2024: Novel ADC and immunotherapy combo shows promise in endometrial cancer subtype
Breakthrough test can evaluate enzyme involved in process associated with cancer cell death
Breakthrough test can evaluate enzyme involved in process associated with cancer cell death
New micromaterial releases nanoparticles that selectively destroy cancer cells
New micromaterial releases nanoparticles that selectively destroy cancer cells
AACR 2024: Preliminary study finds immunotherapy combination before surgery improves outcomes for patients with pancreatic cancer
AACR 2024: Preliminary study finds immunotherapy combination before surgery improves outcomes for patients with...
Microbial signature of colorectal cancer-associated mutations identified in new study
Microbial signature of colorectal cancer-associated mutations identified in new study
Research details adaptation tactics of pancreatic cancer
Research details adaptation tactics of pancreatic cancer
FDA grants accelerated approval to fam-trastuzumab deruxtecan-nxki for unresectable or metastatic HER2-positive solid tumours
FDA grants accelerated approval to fam-trastuzumab deruxtecan-nxki for unresectable or metastatic HER2-positive...
Novel theranostic tool allows for noninvasive identification and treatment of ovarian cancer
Novel theranostic tool allows for noninvasive identification and treatment of ovarian cancer
<1…212213214215216…1208>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top